Fisher Asset Management LLC Has $892,000 Stock Position in The Cooper Companies, Inc. $COO

Fisher Asset Management LLC lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 86.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,886 shares of the medical device company’s stock after selling 70,385 shares during the quarter. Fisher Asset Management LLC’s holdings in Cooper Companies were worth $892,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after buying an additional 7,363 shares in the last quarter. First Trust Advisors LP raised its stake in shares of Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after buying an additional 73,165 shares in the last quarter. Cresset Asset Management LLC bought a new position in shares of Cooper Companies during the 2nd quarter worth about $291,000. Cerity Partners LLC lifted its holdings in shares of Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after acquiring an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. boosted its position in shares of Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after acquiring an additional 973 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

NASDAQ:COO opened at $61.21 on Friday. The stock has a market capitalization of $11.94 billion, a P/E ratio of 30.30, a price-to-earnings-growth ratio of 1.58 and a beta of 0.89. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The firm has a 50 day moving average of $65.96 and a 200-day moving average of $74.87.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the prior year, the company earned $0.92 EPS. Cooper Companies’s revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of several recent research reports. Barclays increased their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Citigroup reaffirmed a “neutral” rating and set a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a report on Thursday. Needham & Company LLC increased their target price on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, March 6th. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research report on Wednesday, March 4th. Finally, Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $88.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.